Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 98 for “"oncogenic pathways"”.
-
Regulation of anoikis by oncogenic pathways
… growth and metastasis. Here we show two novel oncogenic pathways that confer resistance to anoikis in tumor cells. One pathway (chapter 2) signifies a new link between EMT and anoikis-resistance. In chapter 3, we present a new connection between inflammatory signaling pathways and …
-
Oncogenic Pathways and Molecular Prognostics in Neuroblastoma
Neuroblastoma is an embryonal malignancy that accounts for 15% of all cancer related deaths amongst children. Although the overall survival of patients has been improving over the last decades, the high-risk neuroblastoma patients have a survival rate of <50%. Using gene expression microarrays we …
-
Hypoxic gene regulation and oncogenic pathways in neuroblastoma
Neuroblastoma patients show remarkable clinical heterogeneity, with courses ranging from spontaneous regression to fatal tumor progression despite intense multi-modal treatment. Previous studies have shown that hypoxia pushes neuroblastoma cells towards a more immature phenotype, which correlates …
-
Cyclin F: roles in genome stability and oncogenic pathways
… present valuable insights into the implicated pathways and demonstrate clinically-exploitable weaknesses of this axis. Together, results from both projects highlight novel roles for Cyclin F in genome stability maintenance and oncogenic pathways.
-
Targeting drug resistant lung adenocarcinoma through hyperactivation of oncogenic pathways
… mutual exclusivity and synthetic lethality of oncogenic mutations in EGFR and KRAS. However, the signaling vulnerabilities underpinning ERK induced lethality and the clinical relevance remain unclear. To investigate the molecular mechanisms of ERK induced toxicity, I used transcriptional data …
-
Characterisation of oncogenic pathways driving the pathogenesis of prostate cancer
As the leading cancer diagnosis in men, there is an urgent need to elucidate mechanisms underlying prostate cancer (PCa) progression and metastasis. Legumain (LGMN), an asparaginyl endopeptidase, is highly expressed in PCa and correlates with poor prognosis. LGMN is vital to PCa cell viability and …
-
Intervention of non-small cell line cancer oncogenic pathways with delta-tocotrienol
… abilities in NSCLC cells by down-regulating oncogenic pathways such as Notch-1 and NF-ĸB pathways and up-regulating the tumor suppressor pathways such as Bcl-2, caspase-3. Decreased NF- κB activity was observed in both cell lines in combination treatment along with significantly reduced …
-
IDENTIFICATION OF NOVEL ONCOGENIC PATHWAYS IN A PACLITAXEL-RESISTANT MODEL OF TRIPLE NEGATIVE BREAST CANCER
TRIPLE NEGATIVE BREAST CANCER (TNBC) IS MORE AGGRESSIVE THAN OTHER SUBTYPES OF BREAST CANCER IN TERMS OF RELAPSE, TUMOR GRADE, AND LYMPH NODE INVOLVEMENT, AND THE MAINSTAY OF TREATMENT UP TILL NOW IS CHEMOTHERAPY. DESPITE HIGH RESPONSE RATES TO NEO-ADJUVANT CHEMOTHERAPY, APPROXIMATELY 70% OF TNBC …
-
Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone
Wachstumshormon- (GH) Überexpression in transgenen Mäusen ist in hohem Alter mit der Entwicklung von Lebertumoren assoziert. Die präneoplastische Pathologie, die in der Leber von jungen erwachsenen GH-überexprimierenden Mäusen zu beobachten ist, ähnelt der in Patienten mit hohem Risiko für …
-
Investigating the Role of DDX28 RNA Helicase in Oncogenic Pathways and Energy Metabolism in Normoxia and Hypoxia in MDA-MB-231 Breast Cancer Cells
Hypoxia refers to a state of inadequate oxygen supply to cells, commonly found in the core of cancerous tumors. Cellular adaptation to this environment usually leads to more aggressive cancer phenotypes and greater therapeutic resistance. The DEAD-box RNA helicase, DDX28 is involved in mitoribosome …
-
Co-expression of the mammaglobin (SCGB2A2) gene with hsa-miR-184 and hsa-miR-190b indicates their possible role in different oncogenic pathways in Breast cancer
… co-expressed with SCGB2A2, which signaling pathways to better understand SCGB2A2's role in breast cancer. Methods: Using TCGAbiolinks and Firebrowse, miRNA and gene expression data were obtained from 86 patients, with one tumor sample and one normal tissue sample per patient from the TCGA …
-
The role of BAF complexes in regulating transcription factor occupancy
… ensuing transcriptional changes that lead into oncogenic pathways. In this study, ChIP protocols were optimised for the transcription factors OCT4 and LEF1. Following the acute loss of ARID1A via AID degradation or inhibition of SMARCA4/2 via the BRM014 inhibitor across a time series, the …
-
An investigation of mutant p53 function.
… Investigation into mutant p53-mediated oncogenic pathways and the mechanisms through which they are controlled plays an integral role in identifying new therapeutic targets for a range of mutant p53-expressing tumours. To model the initial events that occur in cancer following sporadic …
-
Nuclear receptor 4A1 (NR4A1): a novel drug target for treatment of rhabdomyosarcoma
… in several cancers and is known for its pro-oncogenic activities in solid tumors. NR4A1 plays a crucial role in multiple cancers and regulates expression of important genes that are required for growth and proliferation (EGFR), migration and invasion (integrins), and survival (survivin) of …
-
Targeting EPHA2 in Hepatocellular Carcinoma: Uncovering Its Therapeutic Potential and Beyond
… both JAK1/STAT3 and AKT signaling, two separate oncogenic pathways in HCC. We also identified a small molecule kinase inhibitor of EphA2 that suppresses tumor progression in a murine HCC model. Together, our results suggest EphA2 as a promising therapeutic target for HCC.
-
Investigation of the pseudokinase TRIB2: a double-edged sword in AML
… in cancer, and the role of TRIB2 in the oncogenic pathways of other AML oncogenes have not been fully investigated. Moreover, there is still limited information regarding the expression and function of TRIB2 and its family members, in the haemopoietic system, and how this is altered in …
-
METABOLIC REGULATION OF HIF-1a AND mTORC1 SIGNALLING
Metabolic dysregulation and hyperactivation of oncogenic pathways are hallmarks of oncogenesis often studied as parallel events. Yet, emerging evidences suggest that oncometabolites do crosstalk with oncogenes. I first investigated the link between end-product of glycolysis, pyruvate and the …
-
Targeting the Central Dogma to Inhibit Nodes of Convergence in Cancer
… hallmarks of cancer, and therefore multiple oncogenic signaling programs. One possible way to achieve this is to target nodes of convergence of oncogenic signaling, in which multiple oncogenic pathways depend on one protein for expression or signal proliferation. These nodes can be found …
-
ACTIVITY OF A NOVEL LYN KINASE INHIBITOR IN TRIPLE NEGATIVE BREAST CANCER
… activation of the SFKs contributes to various oncogenic pathways in cancer. Interestingly, of the various breast cancer subtypes, the Triple Negative Breast Cancer (TNBC) is most sensitive to SFK inhibition. Stellar pre-clinical results thus propelled SFK inhibitors into many clinical trials. …
Page 1 of 5